logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Return

Placebo Rates in Metabolic Dysfunction-associated Steatohepatitis Clinical Trials: A Systematic Review and Meta-analysis

delete2025-10-10
delete0
PRE
AI
F
Francisco Idalsoaga
L
Luis Antonio Díaz
S
Saleh Alghsoon
B
Bishoy Lawendy
N
Neha Sharma
H
Hailemichael Desalegn
Y
Yuhong Yuan
M
My Kieu Ha
J
Jessica Le
J
John K MacDonald
M
Marco Arrese
R
Rohit S. Loomba
V
Vipul Jairath
M
Mohammad Qasim Khan
J
Juan Pablo Arab *
DOI：10.1016/j.cgh.2025.09.035delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
High placebo response rates complicate drug development in metabolic dysfunction-associated steatohepatitis (MASH) clinical trials. We performed a meta-analysis to quantify placebo response and assess influencing factors.

Journal

Clinical Gastroenterology and Hepatology cover
Clinical Gastroenterology and Hepatology
IF:
12
Papers:
9.6K
Citations:
3.1W

Organization

Pontificia Universidad Católica de Chile cover
Pontificia Universidad Católica de Chile
Scholars:
1.6K
Papers: 674
Citations: 1.6W
L
london health sciences center
Scholars:
13
Papers: 7
Citations: 0
C
Cleveland Clinic
Scholars:
2.3K
Papers: 878
Citations: 3.4W
U
University of California San Diego
Scholars:
4.6W
Papers: 3.5W
Citations: 924
U
university of toronto
Scholars:
14.5W
Papers: 11.9W
Citations: 165
researcher View more organizations